U.S. CODE
Rulings
AD/CVD
Notices
HTSUS
U.S. Code
Regs
More
Ports
About
Updates
Apps
Larger font
Smaller font
CustomsMobile Pro
beta now open!
Apply for a FREE beta account. Spaces are limited so apply today.
SIGNUP FOR BETA
SEARCH
Toggle Dropdown
Search US Code
Search Leg. Notes
Sort by Rank
Titles Ascending
Titles Descending
10 per page
25 Result/page
50 Result/page
U.S Code last checked for updates: Nov 22, 2024
All Titles
Title 42
Chapter 6A
Subchapter III
Part C
Subpart 9
§ 285i. Purpose of Institute...
Subpart 10 - national institute ...
§ 285i. Purpose of Institute...
Subpart 10 - national institute ...
U.S. Code
§ 285i–1.
Clinical research on eye care and diabetes
(a)
Program of grants
The Director of the Institute, in consultation with the advisory council for the Institute, may award research grants to one or more Diabetes Eye Research Institutions for the support of programs in clinical or health services aimed at—
(1)
providing comprehensive eye care services for people with diabetes, including a full complement of preventive, diagnostic and treatment procedures;
(2)
developing new and improved techniques of patient care through basic and clinical research;
(3)
assisting in translation of the latest research advances into clinical practice; and
(4)
expanding the knowledge of the eye and diabetes through further research.
(b)
Use of funds
Amounts received under a grant awarded under this section shall be used for the following:
(1)
Establishing the biochemical, cellular, and genetic mechanisms associated with diabetic eye disease and the earlier detection of pending eye abnormalities. The focus of work under this paragraph shall require that ophthalmologists have training in the most up-to-date molecular and cell biological methods.
(2)
Establishing new frontiers in technology, such as video-based diagnostic and research resources, to—
(A)
provide improved patient care;
(B)
provide for the evaluation of retinal physiology and its affect on diabetes; and
(C)
provide for the assessment of risks for the development and progression of diabetic eye disease and a more immediate evaluation of various therapies aimed at preventing diabetic eye disease.
Such technologies shall be designed to permit evaluations to be performed both in humans and in animal models.
(3)
The translation of the results of vision research into the improved care of patients with diabetic eye disease. Such translation shall require the application of institutional resources that encompass patient care, clinical research and basic laboratory research.
(4)
The conduct of research concerning the outcomes of eye care treatments and eye health education programs as they relate to patients with diabetic eye disease, including the evaluation of regional approaches to such research.
(c)
Authorized expenditures
(
July 1, 1944, ch. 373
, title IV, § 456, as added
Pub. L. 103–43, title XI, § 1101(a)
,
June 10, 1993
,
107 Stat. 168
.)
cite as:
42 USC 285i-1
.list_box li,p,.cm-search-info,.cm-search-detail,.abt span,.expand-collapse_top
Get the CustomsMobile app!